|
|
Novartis AG
XETRA •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/27/2026 17:35
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization265,910 mln
Float1,608 mln
Earnings Date10/27/2026
P / E
24.94
Premium valuation
Key Fundamentals
EPS5.60
P/E24.94
ROE29.85
ROIC12.08
ROA11.16
Interest Cover11.66
EBITDA, mln18,968
EV / EBITDA15.18
EV / EBIT19.85
Revenue, mln46,960
EV / Revenue6.13
Quote Details
Last
140.00
Change
2.94 (2.15%)
Open
141.28
Volume
8,895
Turnover
1,245,300
Average Volume
5,050.71
Financial Ratios
Pre-Tax Profit Margin28
Current Ratio0.86
Price / Book6.52
Price / Free Cash Flow17.56
Debt / Equity1.18
Price / Sales5.34
PEG Ratio2.22
Financial Strength
Altman Z-Score3.37
Piotroski F-Score
5
/ 9
Beneish M-Score-2.57
Price to Intrinsic Value1.45
Price to Lynch Fair Value2.64
Shiller PE Ratio22.67
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
2.58% |
87
/ 100
 |
| 1 Month |
9.09% |
90
/ 100
 |
| 2 Months |
2.16% |
58
/ 100
 |
| 6 Months |
12.69% |
76
/ 100
 |
| 1 Year |
34.37% |
89
/ 100
|
|
| |
